A new triple therapy for extensively drug-resistant (XDR) tuberculosis and complicated forms of multidrug-resistant (MDR) tuberculosis may replace the multi-drug regimens currently in use and offers some promise in the race to meet WHO End TB goals. An open-label, single-group study across three sites in South Africa has found the all-oral combination of bedaquiline, pretomanid ...
Promise with new triple drug combo for resistant TB
By Mardi Chapman
10 Mar 2020